Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
0.8567
-0.0367 (-4.11%)
At close: Mar 30, 2026, 4:00 PM EDT
0.8750
+0.0183 (2.14%)
Pre-market: Mar 31, 2026, 8:30 AM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 74.54M CAD in the quarter ending December 31, 2025, a decrease of -0.29%. This brings the company's revenue in the last twelve months to 278.39M, up 0.59% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
278.39M CAD
Revenue Growth
+0.59%
P/S Ratio
1.62
Revenue / Employee
289,989 CAD
Employees
960
Market Cap
328.21M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 742.90M |
| Organogenesis Holdings | 564.17M |
| Evolus | 297.18M |
| Ironwood Pharmaceuticals | 296.15M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 236.20M |
| Kamada | 180.46M |
| Anika Therapeutics | 112.82M |
CGC News
- 1 hour ago - Canopy Growth Unveils New Brand ‘Deelish': High THC, Everyday Price - Business Wire
- 15 hours ago - Thinking About Buying Canopy Growth Stock? You May Want to Wait for This to Happen First - The Motley Fool
- 1 day ago - Canopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis Clinic - Business Wire
- 4 days ago - Canopy Growth Announces Storz & Bickel Executive Transition - Business Wire
- 9 days ago - 2 Beaten-Down Stocks That Still Aren't Worth Buying - The Motley Fool
- 12 days ago - Canopy Growth completes takeover of MTL Cannabis - BNN Bloomberg
- 15 days ago - Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue - Business Wire
- 20 days ago - Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands - MarijuanaStocks